Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada, USA
Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology United Kingdom
ADVANCE: Global Awards for Advancing Chronic Pain Research
Release Date:
Partner: Eli Lilly and Company
Review Process: Expert Review Panel
Research Internal Medicine All
New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
Release Date:
Partner: Merck KGaA Darmstadt, Germany and EMD Serono
Review Process: Pfizer Internal
Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Remote Mentoring Programs in RCC
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
Release Date:
Partner: The Sharing Progress in Cancer Care (SPCC)
Review Process: Expert Review Panel
Quality Improvement Oncology All
NSCLC Oncogene Driver Considerations in Testing & Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Canada, USA
Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
Release Date:
Review Process: Pfizer Internal
Education Oncology Canada, USA
Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology France, Germany